| Literature DB >> 35372262 |
Marta I S Veríssimo1, Dmitry V Evtuguin2, M Teresa S R Gomes1.
Abstract
Polyoxometalates (POMs) are a class of metal oxide complexes with a large structural diversity. Effective control of the final chemical and physical properties of POMs could be provided by fine-tuning chemical modifications, such as the inclusion of other metals or non-metal ions. In addition, the nature and type of the counterion can also impact POM properties, like solubility. Besides, POMs may combine with carbon materials as graphene oxide, reduced graphene oxide or carbon nanotubes to enhance electronic conductivity, with noble metal nanoparticles to increase catalytic and functional sites, be introduced into metal-organic frameworks to increase surface area and expose more active sites, and embedded into conducting polymers. The possibility to design POMs to match properties adequate for specific sensing applications turns them into highly desirable chemicals for sensor sensitive layers. This review intends to provide an overview of POM structures used in sensors (electrochemical, optical, and piezoelectric), highlighting their main functional features. Furthermore, this review aims to summarize the reported applications of POMs in sensors for detecting and determining analytes in different matrices, many of them with biochemical and clinical relevance, along with analytical figures of merit and main virtues and problems of such devices. Special emphasis is given to the stability of POMs sensitive layers, detection limits, selectivity, the pH working range and throughput.Entities:
Keywords: POM hybrid materials; electrochemical sensors; optical sensors; piezoelectric sensors; polyoxometalate (POM)
Year: 2022 PMID: 35372262 PMCID: PMC8964365 DOI: 10.3389/fchem.2022.840657
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.545
FIGURE 1Number of polyoxometalate publications from 2010 to 2020 (Web of Science, August 2021).
FIGURE 2Overview of various archetypal POM anions. (A) Keggin, (B) Wells–Dawson, (C) Anderson, (D) Lindqvist, (E) decavanadate, (F) sandwich Keggin, (G) double Keggin, (H) heptamolybdate, (I) α- and (J) γ-octamolybdate, (K) Preyssler, (L) Strandberg, and (M) Krebs-type structure. Blue polyhedra are {MO6} (M = any addenda atom), light green polyhedra {XO } (X = heteroatom), light green spheres sodium, light blue polyhedra {WO6}, light cyan polyhedra {MoO6}, gray polyhedra {VO6}, purple polyhedra and spheres {YO } and Y (Y = second heteroatom), orange polyhedra {PO4}, red spheres oxygen. The most common polyoxometalates archetypes are highlighted with a yellow box. Adapted from Bijelic et al. (2019).
FIGURE 3Overview of the sensor composition: from polyoxometalate analyte recognition layer to the transducer and measured signal.
FIGURE 4Schematic overview of the most common operation principle of a POM-based electrochemical sensor (A), POM-based fibre optic sensor (B) and POM-based mass sensor (C).
POM-based electrochemical sensors for H2O2 detection.
| Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|
| P2W17V/graphite/organoceramic@CPE | b | no | acidic | 4 × 10−5 M | 3 months |
|
| PMo12@Pt | a | no | acidic | 7 × 10−6M | NR |
|
| Fe4POM | a | no | 2.5 | 2 mM | no |
|
| (H6/5bppy)5-P2W18@CPE | b | no | acidic | 1.3 × 10−5 M | 1 month |
|
| P2Mo18/OMC@GCE | b | no | acidic | 53.4 μΜ | NR |
|
| SWCNTs/SiMo12/[Cu(bpy)2]2+@GCE | a | no | 1 | 1 nM | 30 days |
|
| APS/PFeW11@CPE | a | no | 2 | 7.4 μΜ | NR |
|
| VMo12/[BMIM][PF6]@CPE | a | no | 4 | 2.33 μΜ | 2 weeks |
|
| MWCNTs/[C8Py][PF6]/PMo12@GCE | a | no | 1 | 12 μΜ | 20 times a day/5 days |
|
| MPS/B/PFe3Mo9@Au | a | no | 6.2 | NR | NR |
|
| K5 [Ru (bpy)3]-PW18@GCE | b | no | 7 | 0.5 μΜ | 5 weeks |
|
| P2W17Fe/PdNPs@ITO | b | no | 2 | 1 μΜ | 1 month |
|
| P8W48/chitosan/PEI@ITO | n | no | 5 | 1.3 μΜ | 2 months |
|
| AuNPs/PW12/OMC@GCE | a | disinfectant solution | 7 | 0.36 μΜ | 2 weeks |
|
| P2W18/CNTs/AuNPs@ITO | b | no | 2 | 52 nM | 20 days |
|
| PW12/PEI@ITO | a | no | 5 | 8.4 × 10−4 mg/ml | NR |
|
| PtNPs/PMo12/OMC@GCE | a | no | 7 | 1.9 μΜ | 2 weeks |
|
| PMo12/PANI@Au | a | no | acidic | 8.1 μΜ | NR |
|
| PMo12/rGO@GCE | a | no | acidic | 10.2 μΜ | NR |
|
| PMo12/PEI@ITO | a | no | 5 | 0.2 μg ml−1 | 100 cycles |
|
| NENU5 | a | no | 7.4 | 1.03 μΜ | 4 h |
|
| PMo12/AuNPs/rGO@GCE | a | no | 6 | 56 nM | NR |
|
| Ag4La 5SiW12@CPE | a | no | acidic | 5.54 × 10−6 M | NR |
|
| Ag3La 4PW12@CPE | a | no | acidic | 1.28 × 10−6 M | NR |
|
| Ag6Lb 6PMo12@CPE | a | no | acidic | 4.95 × 10−6 M | NR |
|
| Ag4La 2Lb 4GeMo12@CPE | a | no | acidic | 5.45 × 10−6 M | NR |
|
| Cu2(H2bdpm)2P2W18@CPE | b | no | acidic | 1.4 × 10−5 M | NR |
|
| (Cu3(pdp)6Cl2)PCuMo11@CPE | a | no | acidic | 1.7 × 10−5 M | NR |
|
| PEI/rGO/AuNPs/P8W48@ITO | n | no | 7 | 0.31 μΜ | NR |
|
| MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 1 | 241 μΜ | 100 cycles day/5 days |
|
| {K(H2O)}2{Cu2(bim)2}2P2W18@GCE | b | no | acidic | 72.1 mM | 1 month |
|
| [Ag (bpy)][{Ag(Hbpy)}2AlW12@GCE | a | no | acidic | 0.93 μΜ | 1,000 cycles |
|
| [H2en][{Cu(bpy)}3AlW12@GCE | a | no | acidic | 0.86 μΜ | 1,000 cycles |
|
| [Mo-oxo]n/N-MPC@GCRDE | a | no | 7 | 0.23 μΜ | 2 months |
|
| Ag-Fe2O3/PMo12/rGO@GCE | a | local river | 6.8 | 0.2 μΜ | NR |
|
| (Ag7bpy7Cl2)AsW12@GCE | a | human serum | 7.4 | 0.48 μΜ | 3 days |
|
| {P5W30}/Mn/H2bimb@GCE | k | no | 7 | 0.44 mM | No |
|
| {P5W30}/Co./H2bimb@GCE | k | no | 7 | 0.13 mM | 10 h |
|
| {P5W30}/Cu/H2bimb@GCE | k | no | 7 | 0.47 mM | no |
|
| {P5W30}/Zn/H2bimb@GCE | k | no | 7 | 0.62 mM | no |
|
| [Cu(MET)2]Mo8@CPE | j | no | acidic | 6.65 × 10−5 M | NR |
|
| [Cu(bpy)]Mo2@CPE | — | no | acidic | 8.9 × 10−4 M | NR |
|
| Cu3(OH)4(Ptla)2TeMo6@CPE | c | no | acidic | 9.77 × 10−4 M | NR |
|
| Cu2(OH) (Ptep)2Mo8@CPE | — | no | acidic | 4.52 × 10−3 M | NR |
|
Abbreviations as reported by authors. [BMIM][PF6], 1-butyl-3-methylimidazolium hexafluorophosphate; [C8Py][PF6], n-octylpyridinium hexafluorophosphate; APS, 3-aminopropyl(triethoxy)silane; Au, gold; AuNPs, Au nanoparticles; B, ethylamine; bim, biimidazole; bimb, 1,4-bis(1H-imidazol-1-yl)benzene; bppy, 4-(5-(4-bromophenyl)pyridin-2-yl-)pyridine); bpy, 4,40-bipyridyl; CPE, carbon paste electrode; en, ethylenediamine; GCE, glassy carbon electrode; GCRDE, glassy carbon rotating disk electrode; GE, graphite electrode; H2bdpm, 1,1′-bis(3,5-dimethyl-1H-pyrazolate)methane; ITO, indium tin oxide electrode; KB, ketjenblack; La, 2,3-diphenylpyrazine; Lb, 2,3-diphenylquinoxaline; MET, 4-(3-imidazol-1-yl-ethyl)-4H-[1,3,4]triazole; MPS, 3-mercapto-1-propanesulfonic acid; MWCNTs, multi walled carbon nanotubes; N-MPC, nitrogen-doped mesoporous carbon; NR, not reported; OMC, ordered mesoporous carbon; PANI, polyaniline; PdNPs, Pd nanoparticles; pdp, 4-propyl-4, 5-dihydro-1H-pyrazole; PEI, Poly(ethyleneimine); Pt, platinum; Ptep, 1-{2-[3-pyridin-4-yl-(1,2,4)triazol-4-yl]-ethyl}-piperazin; Ptla, 2-[3-pyridin-4-yl-(1,2,4)triazol-4-yl]-ethylamine; rGO, reduced graphene oxide; SWCNTs, single walled carbon nanotubes.
Na6 [H4Fe4(PMo9O34)2(H2O)2]H2O.
[Cu2(BTC)4/3(H2O)2]6 [H3PMo12O40].
POM archetype according to the legend of Figure 2: a) Keggin, b) Dawson, c) Anderson, j) γ-octamolybdate, also including n) crown-shape, k) Preyssler and -) unspecified type.
POM-based electrochemical sensors for other oxidants species.
| Target | Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|---|
| BrO3 − | MWNTs/PMo12@PGE | a | no | acidic | 0.5 μM | NR |
|
| P2Mo18/OMC@GCE | b | no | acidic | 0.922 μM | NR |
| |
| SWCNT/SiMo12/[Cu(bpy)2]2+@GCE | a | no | 1 | 1.1 nM | 30 days |
| |
| SiNiW11/cysteamine@Au | a | no | acidic | 14.88 μM | no |
| |
| Cu2(H2bdpm)2P2W18@CPE | b | no | acidic | 1.8 × 10−5 M | NR |
| |
| (Cu3(pdp)6Cl2)PCuMo11@CPE | a | no | acidic | 2.3 × 10−6 M | NR | ||
| Ag4La 5SiW12@CPE | a | no | acidic | 5.61 × 10−6 M | NR |
| |
| Ag3La 4PW12@CPE | a | no | acidic | 1.69 × 10−5 M | NR | ||
| Ag6Lb 6PMo12@CPE | a | no | acidic | 2.28 × 10−6 M | NR | ||
| MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 1 | 21 μM | 100 cycles a day/5 days |
| |
| SWNTs/ILC12/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles |
| |
| SWNTs/ILC8/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles | ||
| SWNTs/ILC4/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles | ||
| IO3 − | P2Mo18/OMC@GCE | b | no | acidic | 0.377 μM | NR |
|
| MWCNTs/[C8Py][PF6]/PMo12@GCE | a | no | 2.59 | 15 μM | 20 times a day/5 days |
| |
| CoSal/SiW12@CPE | a | no | 0.5 | 48 nM | 50 cycles |
| |
| PMo12/PEI@ITO | a | table salt | 5 | 0.1 μg ml−1 | 100 cycles |
| |
| P2W17V/CNTs/CuONPs | b | table salt | 2.5 | 1.5 × 10−8 M | 100cycles/60 days |
| |
| MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 2.50 | 2 μM | 100 cycles day/5 days |
| |
| SWNTs/ILC12/PMo12@GCE | a | no | acidic | 0.9 μM | 100 cycles |
| |
| SWNTs/ILC8/PMo12@GCE | a | no | acidic | 0.9 μM | 100 cycles | ||
| SWNTs/ILC4/PMo12@GCE | a | no | acidic | 0.9 μM | 100 cycles | ||
| (bdpy)SiNiW11/P-rGO@GCE | a | mineral and tap water, iodized salt | 1.5 | 0.47 nM | 200cycles/1 month |
| |
| IO4 − | MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 2.50 | 4 μM | 100 cycles a day/5 days |
|
| ClO3 − | PMo11 V/PR@ITO | a | no | 2.5 | 220 μM | 8 weeks |
|
| MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 1 | 486 μM | 100 cycles a day/5 days |
| |
| S2O8 2- | SiMo12/rGO@ITO | a | tap water | acidic | 0.129 μM | 100 cycles |
|
| SiMo12/CS/rGO@ITO | a | tap and lake water | acidic | 0.05 μM | 10 min |
| |
| SiMo12/PEDOT/rGO@ITO | a | tap and lake water | acidic | 0.48 μM | 15 min |
| |
| PO4 3- | Mo8@PE | — | saline and seawater | acidic | 6.1 nM | NR |
|
Abbreviations as reported by the authors. [C12Py][PF6], n-dodecyl pyridinium hexafluorophosphate; [C8Py][PF6], n-Octylpyridinium hexafluorophosphate; Au, gold electrode; bdpy, 1,10-(1,4-butanediyl)dipyridinium; bpy, 4,40-bipyridyl; CNTs, carbon nanotubes; CoSal, N,N′-bis(salicylidene)-1,2-phenylenediaminocobalt (III); CS, chitosan; CuONPs, CuO nanoparticles; GCE, glassy carbon electrode; H2bdpm, 1,1′-bis(3,5-dimethyl-1H-pyrazolate)methane; ILCn, CH3N(CH2CH2OH)2(CnH2n+1) Br (n = 4, 8, 12); ITO, indium tin oxide electrode; La, 2,3-diphenylpyrazine; Lb, 2,3-diphenylquinoxaline; NR, not reported; OMC, ordered mesoporous carbon; pdp, 4-propyl-4, 5-dihydro-1H-pyrazole; PE, plastic electrode; PEDOT, poly(3,4-ethylenedioxythiophene); PEI, Poly(ethyleneimine); P-rGO, phosphorus-doped electrochemically reduced graphene oxide; PGE, pencil graphite electrode; PR, para-rosaniline acetate dye; SWCNTs, single walled carbon nanotubes.
POM archetype structure according to the legend of Figure 2: a) Keggin, b) Dawson and -) unspecified type.
POM-based electrochemical sensors for NO2 − detection.
| Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|
| P2Mo18/OMC@GCE | b | no | acidic | 1.78 μM | NR |
|
| PMo12/BC@PE | a | no | acidic | 1.0 × 10−4 M | 100 cycles |
|
| RuSiW10/PEI@ITO | a | no | acidic | 0.1 mM | NR |
|
| P2W18/PVA@ITO | b | no | acidic | 0.96 μM | 100 cycles/2 months |
|
| PEI/PSS/PDDA/P2W17V/CNTs@ITO | b | juices, milk, sausage, pickled vegetable | 7.0 | 0.0367 μM | 150 cycles/50 days |
|
| SiMo12/rGO@ITO | a | tap water | acidic | 7.73 μM | 100 cycles |
|
| PPD/SiW11@BDDE | a | river water | acidic | 20 μM | no |
|
| PMo11/ox-SWCNTs@GCE | a | no | 1 | 3.0 × 10−5 M | 1 month |
|
| PEI/PMo9V3/PEDOT/AuNPs@GCE | a | tap and mineral water, apple juice, milk, yoghurt | 5.1 | 1 nM | 100 cycles/20 days |
|
| Cu2(H2bdpm)2P2W18@CPE | b | no | acidic | 4.9 × 10−5 M | NR |
|
| (Cu3(pdp)6Cl2)PCuMo11@CPE | a | no | acidic | 8.7 × 10−5 M | NR |
|
| Ag4La 5SiW12@CPE | a | no | acidic | 9.22 × 10−5 M | NR |
|
| Ag3La 4PW12@CPE | a | no | acidic | 3.19 × 10−5 M | NR |
|
| Ag6Lb 6PMo12@CPE | a | no | acidic | 7.55 × 10−6 M | NR |
|
| Ag4La 2Lb 4GeMo12@CPE | a | no | acidic | 8.74 × 10−6 M | NR |
|
| P2W18/Zn/dbt@CPE | b | no | acidic | 2.6 × 10−5 M | NR |
|
| PW12/Cd/dbt@CPE | a | no | acidic | 3.3 × 10−5 M | NR |
|
| SiW12/Cd/dbt@CPE | a | no | acidic | 2.2 × 10−5 M | NR |
|
| MWCNTs/[C12Py][PF6]/PMo12@GCE | a | no | 1 | 57 μM | 100 cycles day/5 days |
|
| SWNTs/ILC12/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles |
|
| SWNTs/ILC8/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles |
|
| SWNTs/ILC4/PMo12@GCE | a | no | acidic | 1.3 μM | 100 cycles |
|
| PMo12/MoS2/rGO@GCE | a | lake water | acidic | 0.2 μM | 1 month |
|
| rGO/PANI/As2Mo2@GCE | — | beverages, cucumber extract, water | 4 | 10.71 μM | 2 months |
|
| Zn2 (bte)4SiMo12@CPE | a | no | acidic | 6.1 × 10−3 M | NR |
|
| CuII 4(btmc) (ctcm)4Mo8at CPE | — | no | acidic | 1.4 × 10−7 M | NR |
|
| CuII 4(mct)2 (ctcm)2(H2O)6Mo8@CPE | — | no | acidic | 5.6 × 10−7 M | NR |
|
| CuII(dm4bt)Mo3@CPE | — | no | acidic | 1.135 × 10−7 M | NR |
|
| CoII(dm4bt)Mo2@CPE | — | no | acidic | 1.264 × 10−6 M | NR |
|
| CoII(H2bdpm)Mo2@CPE | — | no | acidic | 4.26 × 10−8 M | NR |
|
| Ag(Py2Piz)2PW12@GCE | a | no | acidic | 2.2 × 10−4 M | NR |
|
| Ag4(AcyPh)4SiMo12@GCE | a | no | acidic | 2.0 × 10−4 M | NR |
|
| Ag2(Py3Piz)2(H2O)2SiMo12@GCE | a | no | acidic | 2.26 × 10−4 M | NR |
|
| Ag/Py2TTz/PMo12@GCE | a | no | acidic | 1.2 × 10−5 M | NR |
|
| [Cu(MET)2]Mo8@CPE | j | no | acidic | 8.45 × 10−5 M | NR |
|
| [Cu(bpy)]Mo2@CPE | — | no | acidic | 8.75 × 10−4 M | NR |
|
| Cu3(OH)4(Ptla)2TeMo6@CPE | c | no | acidic | 1.57 × 10−4 M | NR |
|
| Cu2(OH) (Ptep)2Mo8@CPE | — | no | acidic | 1.02 × 10−2 M | NR |
|
| {CuI 5 [4-atrz]6}5+-PMo12@GCE | a | no | acidic | 1.3 × 10−5 M | 1,000 cycles |
|
| {CuI 5 [4-atrz]6}5+-PW12@GCE | a | no | acidic | 2.2 × 10−5 M | 1,000 cycles |
|
| {CuI 5 [4-atrz]6}5+-SiW12@GCE | a | no | acidic | 1.2 × 10−5 M | 1,000 cycles |
|
| (bdpy)PW11Co/MWCNTs-COOH@GCE | a | mineral and industrial water | 1.5 | 0.63 μM | 220 cycles/1 month |
|
Abbreviations as reported by the authors. [C12Py][PF6], n-dodecyl pyridinium hexafluorophosphate; 4-atrz, 4- amino-triazole; AuNPs, Au nanoparticles; BC, bacterial cellulose; BDDE, boron doped diamond electrode; bdpy, 1,10-(1,4-Butanediyl)dipyridinium; bpy, 4,40-bipyridyl; bte, 1,2-bis(1,2,4-triazol-1-yl)ethane; btmc, 1,4-bis(1,2,4-triazol-1-methyl)cyclohexane; CNTs, carbon nanotubes; CPE, carbon paste electrode; ctcm, C-[4-(1,2,4)Triazol-4-ylmethylcyclohexyl]-methylamine; dbt, 2,2′-dimethyl-4, 4′-bithiazole; dm4bt, 2,2′-dimethyl-4,4′-bithiazole; GCE, glassy carbon electrode; H2bdpm, 1,1′-bis(3,5-dimethyl-1H-pyrazolate)methane; ILCn, CH3N(CH2CH2OH)2(CnH2n+1) Br (n = 4, 8, 12); ITO, indium tin oxide electrode; La, 2,3-diphenylpyrazine; Lb, 2,3-diphenylquinoxaline; mct, 4-(4-Methyl-cyclohexylmethyl)-4H-[1,2,4]triazole; MET, 4-(3-imidazol-1-yl-ethyl)-4H-[1,3,4]triazole; MWCNTs, multi walled carbon nanotubes; NR, not reported; OMC, ordered mesoporous carbon; ox-SWCNts, oxidized single walled carbon nanotubes; PANI, polyaniline; PDDA, poly diallyl dimethyl ammonium; pdp, 4-propyl-4,5-dihydro-1H-pyrazole; PE, plastic electrode; PEDOT, poly(3,4-ethylenedioxythiophene); PEI, Poly(ethyleneimine); PPD, p-phenylenediamine; PSS, poly(styrenesulfonate); Ptep, 1-[2-(3-pyridin-4-yl-[1,2,4]triazol-4-yl)-ethyl]-piperazine; Ptla, 2-[3-pyridin-4-yl-(1,2,4)triazol-4-yl]-ethylamine; PVA, poly(vinyl alcohol); Py2Piz, 4,5-bis(2-pyridinyl)imidazole; Py2TTz, 2,5-bis(4-pyridyl)thiazolo[5,4-d]thiazole; Py3Piz, 2-(4-pyridyl)4,5-di(2-pyridinyl)imidazole; rGO, reduced graphene oxide; SWCNTs, single walled carbon nanotubes.
POM archetype according to the legend of Figure 2: a) Keggin, b) Dawson, c) Anderson, j) γ-octamolybdate, and -) unspecified type.
POM-based electrochemical sensors for biomolecules and bio-related species.
| Target | Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|---|
| Dopamine | P2W16V2/Au-PdNPs@ITO | b | serum | 7 | 0.83 μM | 300 cycles |
|
| PMo9V3/PtNPs@ITO | a | dopamine hydrochloride injection | 6.5 | 1.3 × 10−7 M | 100 cycles |
| |
| PMo11V/PEI/CoTsPc-@ITO | a | blood serum | 6.5 | 1.3 × 10−8 M | 500 cycles |
| |
| PMo12/PEI@ITO | a | serum | 5 | 0.2 μg ml−1 | 100 cycles |
| |
| Cu3Mo5P2/rGO@GCE | — | artificial cerebrospinal fluid, human blood serum | 7 | 80.4 × 10−9 M | 1 week |
| |
| PMo9V3/Pd-PtNPs/MWCNTs@ITO | a | human serum and dopamine hydrochloride injections | 7.3 | 1.25 × 10−8 M | 100 cycles |
| |
| PVIM-Co5POMa/N-CNTs@GE | a | dopamine hydrochloride injections | 7.4 | 500 pM | 100 cycles |
| |
| GeW12/CFMWCNTs/Nafion@GCE | a | no | 3.6 | 1.23 μM | 180 cycles |
| |
| PtNPs/IMo6/GO@GCE | c | human serum | 1.3 | 0.22 μM | 100 cycles/20 days |
| |
| P2W17V/CS@ITO | b | human serum | 7.0 | 0.18 μM | 100 cycles |
| |
| Ce-POM | — | no | 7.0 | 1.61 μM | 180 cycles |
| |
| V10O28/NU-902@FTO | e | no | 4.5 | 2.1 μM | 20 cycles |
| |
| Ce-POM | — | no | 3.0 | 0.053 μM | 100 cycles/7 days |
| |
| [Ag5 (trz)4]2·PMo12/SWCNTs-COOH@GCE | a | human serum | 7.0 | 8.6 nM | 100 cycles/1 month |
| |
| PMo12 [6]catenane/rGO@GCE | a | human serum | 2.0 | 0.065 μM | 50 cycles/1 week |
| |
| Ascorbic acid | PEI/RuSiW10@ITO | a | no | 0.08 mM | NR |
| |
| [BMIM]6-P2Mo18@GCE | b | no | 0–7 | <0.1 μM | 2 weeks |
| |
| SiNiW11/cysteamine@Au | a | no | 14.60 μM | no |
| ||
| P2W16V2/Au-PdNPs@ITO | b | fruit juice | 7 | 0.43 μM | 300 cycles |
| |
| PMo12/GS@GCE | a | vitamin C tablets | 7.2 | 0.5 × 10−6 M | 1 month |
| |
| PW12/PEI@ITO | a | soft fruit drinks | 5 | 6.4 × 10−4 mg/ml | NR |
| |
| PMo12/PEI@ITO | a | fruit juice | 5 | 0.43 μg ml−1 | 100 cycles |
| |
| PtNPs/IMo6/GO@GCE | c | human serum | 1.3 | 6.42 μM | 100 cycles/20 days |
| |
| P2Mo17V/Ru (bpy)3/CS-PdNPs@ITO | b | juice | 7 | 0.1 μM | 30 days |
| |
| Creatinine | MIP/AgNPs/PW12/rGO@GCE | a | saliva and serum | 6 | 1.51 × 10−11 M | 10 days |
|
| Cholesterol | PVIM-Co5POM | a | human blood serum | 7.4 | 1 fM | 100 cycles |
|
| Bilirubin | MIP/PW12/C3N4NTs@GCE | a | human plasma | 4.0 | 0.1 p.m. | 60 days |
|
| Xanthine | Fc/PMo6W6/rGO@GCE | a | human urine | 6.0 | 10.1 nM | 100 cycles/2 weeks |
|
| Glucose | Fe4POM | a | no | 2.5 | 1.2 mM | no |
|
| MPS/B/PFe3Mo9/B/GOx@Au | a | no | 6.2 | NR | NR |
| |
| PMo12/rGO/GOx@GCE | a | no | 67.9 μM | NR |
| ||
| P2Mo18/PMA/MWCNTs@GCE | b | no | 7.0 | NR | 15 days |
| |
| PW9/PAAC/GOx@GE | a | Fizzy drink, Cherry juice | 6.0 | 0.099 mM | 4 weeks |
| |
| Co2W11/MWCNTs@GE | a | coke, juice | 1.21 μM | 5 weeks |
| ||
| Uric acid | Ce-POM | a | no | 7.0 | 5.41 μM | 180 cycles |
|
| PtNPs/IMo6/GO@GCE | c | human serum | 1.3 | 0.72 μM | 100 cycles/20 days |
| |
| Cubix/P2W18@GCE | b | no | 6.0 | 4.97 × 10−7 M | 50 cycles/30 days |
| |
| rGO/AuNPs/P2W18@ITO | b | human serum | 7.0 | 0.15 μM | 50 cycles/30 days |
| |
| bix/P2W18@GCE | b | human urine | 3.0 | 5.85 × 10−7 M | 5 cycles/4 weeks |
| |
| AM-LnSTsPOM/CFMWCNTs@GCE | a | no | 7.0 | 1.69 μM | 160 cycles |
| |
| NADH | AuNPs/PW12/OMC@GCE | a | no | 7 | 0.41 μM | 2 weeks |
|
| Ru (bpy)3 2+/PMo12@ITO | a | no | 7.0 | 1.67 × 10−8 M | 21 cycles/2 weeks |
| |
| Ru (bpy)3 2+/PMo12/mrGO@mGCE | a | yes | 7.4 | 0.1 nM | 28 cycles/1 month |
| |
|
| SiW11Sn-dATPs@Au | a | no | 0.6 nM | NR |
| |
| SiW11Sn-dGTP@Au | a | no | 0.3 nM | NR | |||
| SiW11Sn-dATP/dGTP@Au | a | no | 0.7 nM | NR | |||
| P2W17Sn-dATP@Au | b | no | 1.12 nM | NR | |||
| P2W17Sn-dGTP@Au | b | no | 1.70 nM | NR | |||
| P2W17Sn-dATP/dGTP@Au | b | no | 1.50 nM | NR | |||
| miRNA21 | PMo12-MoS2/
| a | human serum | 7.4 | 0.11 fM | 10 cycles/15 days |
|
| Guanine and Adenine | PNiW11/PDDA/MWCNTs@GCE | a | salmon sperm | 2 | 0.24 μM and | NR |
|
| 0.1 μM | NR | ||||||
| Osteopotin | PPy/Ti3C2Tx/PMo12@GCE | a | human serum | 7.4 | 0.98 fg ml−1 | 10 cycles/15 days |
|
| L-cysteine | VMo12/[BMIM][PF6]@CPE | a | food supplement | 0.085 mM | NR |
| |
| CoSal/SiW12@CPE | a | human serum, urine, N-acetylcysteine effervescent tablets | 5.0 | 4.9 nM | 2 months |
| |
| CoSal/SiW12@CPE | a | no | 5 | 967 nM | 50 cycles |
| |
| L-tyrosine and L- tryptophan | PW12/rGO@GCE | a | human serum | 6 | 2 × 10−12 M | 45 days |
|
| Folic acid | PPy/PMo2W9/AuNPs@Au | a | human serum, vitamin supplements | 6.0 | 0.12 nM | NR |
|
| PEI/P2Mo16V2/rGO@GCE | b | human serum | 7.4 | 2.84 × 10−10 M | 60 days |
| |
| Cardiac troponin I | {Mo368}/FeOOH/Bi2S3/AuNPs@ITO | q | human serum | 0.76 pg ml−1 | NR |
|
Abbreviations as reported by the authors.[BMIM][PF6], 1-butyl-3-methylimidazolium hexafluorophosphate; AgNPs, silver nanoparticles; AM-LnSTsPOM, alkali-metal–lanthanide embedded selenotungstates; AuNPs, gold nanoparticles; Au-PdNPs, gold and palladium nanoparticles; B, ethylamine; bix, 1,4-bis(imidazol-1-ylmethyl) benzene; CFMWCNTs, carboxyl functionalized multi-walled carbon nanotubes; CoSal, N,N′-bis(salicylidene)-1,2-phenylenediaminocobalt (III); CoTsPc, cobalt(II) tetrasulfonate phthalocyanine; CS, chitosan; CS-PdNPs, Chitosan and palladium nanoparticles; Fc, ferrocene; FTO, fluorine doped tin oxide; GCE, glassy carbon electrode; GO, graphene oxide; GOx, glucose oxidase; GS, graphene sheets; ITO, indium tin oxide electrode; mGCE, magnetic glassy carbon electrode; MIP, molecularly imprinted polymer; MPS, 3-mercapto-1-propanesulfonic acid; mrGO, magnetic reduced graphene oxide; MWCNTs, multi walled carbon nanotubes; N-CNTs, nitrogen-doped carbon nanotubes; N-HCSs, nitrogen-doping hollow carbon spheres; N-MPC, nitrogen-doped mesoporous carbon; NR, not reported; OMC, ordered mesoporous carbon; PAAC, 3-Amino-9-ethylcarbazole polymer film; PDDA, poly diallyl dimethyl ammonium; PdNPs, palladium nanoparticles; PEI, Poly(ethyleneimine); PMA, 1-pyrenemethylamine; PPy, polypyrrole; PtNPs, platinum nanoparticles; Pt-PdNPs, platinum and palladium nanoparticles; PVIM+, poly(vinylimidazolium) cation; rGO, reduced graphene oxide; SWCNTs-COOH, carboxyl functionalized single walled carbon nanotubes; trz, 3-mercapto-1, 2,4-triazole.
Na12 [WCo3(H2O)2(CoW9O34)2].
[H2N(CH3)2]8Na [CeNa(H2O)4(OH)WO(H2O) (B-α-SeW9O33)2]⋅18H2O.
Na16H6{[Ce3W4O10(H2O)9 (CH3COO)3]2 (Se2W7O30) (B-α-SeW9O33)4}·(C5H8NBO3)·119H2O.
Na6 [H4Fe4(PMo9O34)2(H2O)2].H2O.
POM archetype structure according to the legend of Figure 2: a) Keggin, b) Dawson, c) Anderson, d) Lindqvist, e) decavanadate, and also including q) hedgehog-shape, and -) unspecified type.
POM-based electrochemical sensors for medicines, pesticides, and toxic contaminants.
| Target | Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|---|
| Clenbuterol and Ractopamine | PV8Mo4/ZrO2@GCE | a | pork | 1.0 | 5.03 × 10−9 M and 9.3 × 10−7 M | 2 weeks |
|
| Acetaminophen | AuNPs/PW12/OMC@GCE | a | paracetamol tablets | 7 | 0.29 μM | NR |
|
| PMo11V/N-CNTs@GCE | a | no | 2.5 | 1.0 × 10−6 M | NR |
| |
| PdNPs/PW12/N-HCSs@GCE | a | paracetamol tablets | 7.4 | 3 nM | 1 h/2 weeks |
| |
| La-GeW12/CFMWCNT@GCE | a | no | 8.0 | 1.07 μM | 180 cycles |
| |
| Tb-GeW12/CFMWCNT@GCE | a | no | 8.0 | 1.08 μM | 180 cycles | ||
| AuNPs/SiW11Cu/MWCNTs@GCE | a | paracetamol tablets, mineral and river water | 7 | 0.42 μM | 12 days |
| |
| Ce-POM | — | no | 3.0 | 2.03 μM | 100 cycles/7 days |
| |
| Triclosan | AuNPs/PW12/rGO@GCE | a | wastewater, lake water | 7.0 | 0.15 nM | 30 days |
|
| Ceftizoxime | PNC/rGO@PGE | k | ampoules, blood serum | 3.0 | 1.8 p.m. | 1 month |
|
| Methyldopa | PMo12/rGO@PGE | a | human blood serum, urine, and milk | 2.8 | 1.2 × 10−10 M | 2 weeks |
|
| Paroxetine | PW12/rGO@PGE | a | paroxetine tablets, human serum, urine | 7.0 | 9.0 × 10−10 M | 15 days |
|
| Sildenafil | MIP/AuNPs/NaP5W30/MWCNTs@PGE | k | human plasma, milk | 7.0 | 0.033 nM | 10x, 1 month |
|
| Simazine | MIP/PtNPs/PW12/MWCNTs@GCE | a | industrial wastewater | 4.0 | 2.0 × 10−11 M | NR |
|
| Hydrazine | P2W17Fe/PdNPs@ITO | b | no | 2 | 1.5 μM | 1 month |
|
| Hydrazine sulfate and Nitrobenzene | PtNPs/PMo12/OMC@GCE | a | no | 7 | 3.41 μM and 3.82 μM | 2 weeks |
|
| Hydroquinone, Catechol and Resorcinol | rGO/SiW12@GCE | a | diphenolic compounds, underground and lake water | 4.5 | 50 nM, 40 nM and 90 nM | 6 weeks |
|
| N-hydroxysuccinimide | PtNPs/PW12/2D-hBN@CPE | a | drinking, lake, and river water | 8.0 | 60 nM | 45 days |
|
| Chlorogenic acid | AuNPs/PW12/MacroPC@GCE | a | pharmaceutical | 7.0 | 2.15 nM | 2 weeks |
|
| Mycertin | P2W18/SnO2/AuNPs@ITO | b | juice | 3 | 67 nM | 20 cycles/1 week |
|
| Ochratoxin A | MIP/AgNPs/PW12/rGO@GCE | a | grape juice and wine | 6.0 | 1.6 × 10−11 M | 30 days |
|
| Citrinin | MIP/PtNPs/PW12/rGO@GCE | a | rye samples | 6.0 | 2.0 × 10−13 M | 45 days |
|
| Propylparaben | PPy/β-CD/PMo12@PGE | a | cleansing micellar solution | 6.0 | 0.04 μM | 5 cycles |
|
| Diphenylamine | PMo12/GO@GCE | a | apple juice | 7.0 | 6.0 nM | 2 weeks |
|
| Diazinon | MIP/AuNPs/PW12/2D-hBN@GCE | a | fruit juice | 6.0 | 3.00 × 10−12 M | 45 days |
|
| Bisphenol A | AgPMo12@Au | a | river water, milk, human serum | 7.4 | 0.2 fg ml−1 | 7 cycles/15 days |
|
| AuNPs/SiW11Cu/MWCNTs@GCE | a | Mineral and local river water | 7 | 0.89 μM | 12 days |
| |
|
| MIP/PW12/C3N4NTs@GCE | a | orange juice | 7.0 | 2.0 × 10−11 M | 60 cycles/60 days |
|
Abbreviations as reported by the authors. 2D-hBN, two dimensional hexagonal boron nitride nanosheets; β-CD, ß-cyclodextrin; AgNPs, silver nanoparticles; Au, gold electrode; AuNPs, gold nanoparticles; C3N4NTs, carbon nitride nanotubes; GCE, glassy carbon electrode; GO, graphene oxide; ITO, indium tin oxide electrode; MacroPC, macroporous carbon; MIP, molecularly imprinted polymer; MWCNTs, multi-walled carbon nanotubes; N-CNTs, nitrogen-doped carbon nanotubes; NR, not reported; OMC, ordered mesoporous carbon; PdNPs, palladium nanoparticles; PGE, pencil graphite electrode; PNC, preyssler nanocapsules; PPy, polypyrrole; PtNPs, platinum nanoparticles; rGO, reduced graphene oxide.
Na16H6{[Ce3W4O10(H2O)9-(CH3COO)3]2(Se2W7O30) (B-α-SeW9O33)4}·(C5H8NBO3)·119H2O.
POM archetype structure according to the legend of Figure 2: a) Keggin, b) Dawson, and including k) Preyssler, and -) unspecified type.
POM-based electrochemical sensors for metal ions.
| Target | Hybrid material@Electrode | POM archetype | Matrix | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|---|
| Cr6+ | Co/{P4Mo6}2@GCE | r | lake water | acidic | 0.026 μM | 5.5 h |
|
| Ni/{P4Mo6}2@GCE | r | no | 0.321 μM | NR | |||
| Cd/{P4Mo6}2@GCE | r | no | 0.082 μM | NR | |||
| CuII 4(btmc) (ctcm)4Mo8@ CPE | — | no | acidic | 7.4 × 10−8 M | NR |
| |
| CuII 4(mct)2 (ctcm)2(H2O)6Mo8@CPE | — | no | 2.5 × 10−7 M | NR | |||
| CuII(dm4bt)Mo3@CPE | — | no | 6.5 × 10−7 M | NR | |||
| CoII(dm4bt)Mo2@CPE | — | no | 7.35 × 10−6 M | NR | |||
| CoII(H2bdpm)Mo2@CPE | — | no | 1.03 × 10−6 M | NR | |||
| (H2bpp)2 [Na4Fe(H2O)7]FeP4Mo6@GCE | r | lake water | acidic | 0.174 μM | NR |
| |
| (H2bpp)6 (bpp)2]FeP4Mo6@GCE | r | no | 0.33 μM | NR | |||
| H3 [Cu2(4-dpye)2PMo12@CPE | a | no | acidic | 1.27 × 10−7 M | NR |
| |
| H [Cu2(4-Hdpye)2PMo12@CPE | a | no | 1.71 × 10−7 M | NR | |||
| {P4Mo6}/Cu/Mn/BBTZ@GCE | r | lake water | pH 0 | 1.59 nM | 10 h |
| |
| {P4Mo6}/Cu/Mn/BBTZ@GCE | r | 1–5 | <15 nM | ||||
| {P4Mo6}/Na/Mn/BBTZ@GCE | r | 0 | 2.91 nM | 10 h | |||
| {P4Mo6}/Na/Mn/BBTZ@GCE | r | lake water | 1–5 | <24 nM | |||
| Cu2(OH) (Ptep)2Mo8@CPE | — | no | acidic | 1.34 × 10−4 M | NR |
| |
| {CuI 5 [4-atrz]6}5+-PMo12@GCE | a | no | acidic | 5.4 × 10−6 M | 1,000 cycles |
| |
| {CuI 5 [4-atrz]6}5+-PW12@GCE | a | no | 5.4 × 10−6 M | 1,000 cycles | |||
| {CuI 5 [4-atrz]6}5+-SiW12@GCE | a | no | 4.2 × 10−6 M | 1,000 cycles | |||
| Cd2+ and Pd2+ | PW12/Cys@Au | a | industrial wastewater | acidic | 9.0 nM and 4.0 nM | 1 month |
|
Abbreviations as reported by the authors. 4-atrz, 4- amino-triazole; Au, gold, BBTZ, 1,4-bis(1,2,4-triazol-1-ylmethyl) benzene; bpp, 1,3-bi(4-pyridyl)propane; btmc, 1,4-bis(1,2,4-triazol-1-methyl)cyclohexane; CPE, carbon paste electrode; ctcm, C-(4-[1,2,4]Triazol-4-ylmethylcyclohexyl)-methylamine; cys, cysteine; dm4bt, 2,2′-dimethyl-4, 4′-bithiazole; dpye, N,N′-bis (4-pyrimidinecarboxamido)-1,2-ethane; GCE, glassy carbon electrode; mct, 4-(4-Methyl-cyclohexylmethyl)-4H-[1,2,4]triazole; NR, not reported; Ptep, 1-[2-(3-pyridin-4-yl-[1,2,4]triazol-4-yl)-ethyl]-piperazine.
POM archetype structure according to the legend of Figure 2: a) Keggin and including r) hourglass type and -) unspecified type.
POM-based absorption optical sensors.
| Targets | POM or POM hybrid material | POM archetype | Matrix | Chromogenic substrates/reagents | pH | Limit of detection | Stability studies | References |
|---|---|---|---|---|---|---|---|---|
| H2O2 and Glucose | PW12 | a | no | TMB | 3.0 | NR | NR |
|
| GOx | 7.0 and 3.0 | NR | NR | |||||
| SiW12 | a | human blood | TMB | 4.0 | 0.4 μM | NR |
| |
| GOx | 7.0 and 4.0 | 0.5 μM | NR | |||||
| H2O2 and Citric acid | Ni4(Trz)6/SiW12/PDDA-rGO | a | orange juice | TMB | 2.5 | 0.49 μM | NR |
|
| H2O2, TMB | 2.5 | 2.07 μM | 5 runs | |||||
| H2O2 and Sarcosine | FA-PMo4V8 | a | urine | TMB | 4.0 | 0.012 μM | NR |
|
| 7.3 and 4.0 | 0.311 μM | NR | ||||||
| H2O2 | PW12/GO/FF | a | no | TMB | 3 | 0.11 μM | 10 batches |
|
| NH3 | Lcys/SiW12 | a | no | > 5.2 | NR | NR |
| |
| Hg2+ | MLPOM | d | industrial sewage | methanol | 0.05 μM | NR |
| |
| cancer cells | FA-PVnMo12-n | a | 3 types of cancer cells | TMB | 7 | NR | NR |
|
| UV light | PW12/SPS/PP | a | gly, ethanol | NR | NR |
| ||
| PMo12/LA | a | NR | 8 weeks |
| ||||
| Dopamine and Ractopamine | SiW9Co3 | a | no | H2O2 | 5.38 × 10−6 M and 7.94 × 10−5 M | NR |
| |
| Formaldehyde | PMo10V2/PVC/NPOE | a | commercial milk | 0.2 mg L−1 | 8 days |
| ||
| Dimethoate | PW12/Myr | a | lake water and juice | 0.9 ng/ml | NR |
| ||
| ZnCl2.2H2O | imi-SiMo12 | a | no | 0.15 μM | NR |
| ||
| Glutathione | Mo-based POM/CR | — | mice | 7.4 | 0.51 mM | 48 h |
|
Abbreviations as reported by the authors. CR: croconaine; FA, folate acid; FF, diphenylalanine; Gly, glycerol; GO, graphene oxide; GOx, glucose oxidase; imi, imidazole; Lcys, L-cysteine; LA, lactic acid; Myr, myristoylcholine; NPOE, 2-nitrophenyl octyl ether; NR, not reported; PDDA, polydiallyldimethylammonium chloride; PP, polypropylene film; PVC, polyvinyl chloride; rGO, reduced graphene oxide; SPS, sulphonated polystyrene; TMB, 3,3′,5,5′-tetramethylbenzidine; Trz, 1,2,4-triazole.
(n-Bu4N)2 [Mo5NaO13(OCH3)4(NO)].
POM archetype structure according to the legend of Figure 2: a) Keggin, d) Lindqvist and -) unspecified type.
Lanthanides POM-based fluorescence optical sensors.
| Targets | POM or POM hybrid material | POM archetype | Matrix | Detection limit | Operation mode | References |
|---|---|---|---|---|---|---|
| Zn2+ and UV light | EuW10/PyC10C12N | d | no | NR | luminescent logic gate with dual output |
|
| solar UV-light | EuW10/PVP/PEI/AV2+ | d | no | NR | portable solar UV-light sensor |
|
| HCl and NH3 | EuW10/agarose | d | no | NR | luminescence sharply decreases with HCl gas and recover upon subsequently exposing the films to NH3 gas |
|
| TbW10/agarose | d | no | 0.2731 mM | luminescence sharply decreases with HCl gas and recover upon subsequently exposing the films to NH3 gas |
| |
| Metanil Yellow,Allura red, Auramine O,Orange II | PrW10/CNO | d | no | 3.83 nmol ml−1 2.90 nmol ml−1 4.73 nmol ml−1 4.14 nmol ml−1 |
| |
| Fe3+ and amino-acids | EuW10/UiO-67 | d | no | 37 μΜ | luminescence intensity quenched by Fe3+ and enhanced by amino-acids |
|
| MnO4 −and Cr3+ | EuW10/[C14-2-C14im]Br2 | d | no | 1.70 μΜ and 0.926 mM | off-luminescence chemical sensor |
|
| Cr3+ and Ca2+ | EuPW11/PHBA | a | no | 1.423 mM and 0.676 mM | luminescence intensity quenched by Cr3+, and enhanced by Ca2+ |
|
| Ascorbic acid and NO2 − | EuSiMoW10 | — | urine, spinach | 0.53 μΜ (UV-Vis) and 4.67 μΜ (fluorescence) 1.16 mM (UV-Vis) and 5.39 mM (fluorescence) | reversible change of colour and luminescence |
|
| Cu2+ | EuMnMo6/PPCT | c | no | 24 nM |
| |
| Vitamin C and H2O2 | TbP2Mo18 | b | no | NR |
| |
| Ba2+ | Eu-arsenotungstates/H2tpdc | — | no | 1.19 × 10−3 mM | good recognition responses toward detecting the Ba2+ ion in the absence of Ca2+ or Sr2+ ions in aqueous system |
|
| Cu2+ and L-cysteine | EuSe3W14
| b | no | 1.24 × 10−3 mM and 2.17 × 10−4 mM | turn-off/on |
|
| EuTeW9
| — | no | 8.82 × 10−6 mM and 1.75 × 10−4 mM | turn-off/on |
| |
| Temperature | EuW10/Tb-TATB | d | no | NR |
| |
| Ag+ and cholyglycine | Eu4W8/EB-TFP | — | tap and river water | 0.014 μg ml−1 and 0.024 μg ml−1 | luminescence turn-on/off |
|
Abbreviations as reported by the authors. AV2+, N,N′-bis(δ-aminopropyl)-4,4′-bipyridine bromide hydrobromide; CNO, carbon nano-onion; EB, ethidium bromide; glu, D-gluconic acid; NR, not reported; PEI, polyethyleneimine; PHBA, p-hydroxybenzoic acid; PPCT, 4′ 2,2':6′,2″para-phenylcarboxyl-terpyridine; PVP, polyvinylpyrrolidone; PyC10C12N, trans-10-(4-(4′-pyridylvinylene)-phenyl)oxydecyldodecyldimethylammonium bromide; TATB, triazine-1, 3,5-tribenzoic acid; TFP, 1,3,5-triformylphloroglucinol; tpdc, 2,5- thiophenedicarboxylic acid; UiO-67, zirconium luminescent metal-organic framework.
[H2N(CH3)2]10H3{SeO4Eu5(H2O)8 [Se2W14O52]2}·40H2O.
K14H10 [Eu4(H2O)4W6(H2glu)4O12(B-α-TeW9O33)4]·60H2O.
POM archetype structure according to the legend of Figure 2: a) Keggin, b) Dawson, c) Anderson, d) Lindqvist and -) unspecified type.
POM-based fluorescence optical sensors.
| Target | POM or POM hybrid material | POM archetype | Matrix | Substrates | Operation mode/Limit of detection | References |
|---|---|---|---|---|---|---|
| Cu2+ and Pb2+ | SiW10/dansyl | a | no | Fluorescence quenched by Cu2+ and enhanced by Pb2+ |
| |
| pH | Mo8/norfloxacine | j | no | Acid-base switch |
| |
| VOCs | Mo8/[IrIII(PPy)2 (bpy)]+ | — | no | Depending on VOC polarity |
| |
| Picric acid and Pd2+ | V10O28/Cu-pyno-NEt | e | no | 0.18 ppb and 0.80 ppb, for picric acid and Pd2+, respectively |
| |
| H2O2 | SiW9 | a | water | BA TH HPPA | 6.7 × 10−9 M 2.2 × 10−7 M 9.6 × 10−6 M |
|
| Hg2+ | Zn-dbt/P2W18 Cd-dbt/P2W18 Cd-dbt-Cl/PW12 Cd-dbt/SiW12 | b | no | NR |
| |
| Hg2+ | Ag- Py2TTz/PMo12 | a | no | NR |
| |
| Hg2+ | Cu-dm4bt/PMo12 | a | no | NR |
| |
| Hg2+ | Zn-MET/CrMo6 Cu-MET/CrMo6 | j j | no | For both POM composites, the fluorescence is quenched to a large extent by Hg2+ |
| |
| Dopamine | FeMo6/rGO | c | Human serum and dopamine hydrochloride injection | OPD ABTs TMB | two consecutive “turn on” fluorescence 0.0112 μM |
|
Abbreviations as reported by the authors. ABTs, 2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid); BA, benzoic acid; dm4bt, 2,2′-dimethyl-4, 4′-bithiazole; HPPA, 3-(4-hydroxyphenyl) propionic acid; MET, 4-(3-imidazol-1-yl-ethyl)-4H-[1,3,4]triazole; NEt, Triethylamine; NR, not reported; OPD, o-phenylenediamine, PPy, polypyrrole; Py2TTz, 2,5-bis(4-pyridyl)thiazolo[5,4-d]thiazole; Pyno, 4-picoline N-oxide; rGO, reduced graphene oxide; TH, thiamine, TMB, 3,3′,5,5′-tetramethylbenzidine.
POM archetype structure according to the legend of Figure 2: a) Keggin, b) Dawson, c) Anderson, e) decavanadate, j) γ-octamolybdate, and -) unspecified type.
FIGURE 5Summary of the most reported materials used in polyoxometalate functionalized sensors.